CHAM
IOVA icon

Clear Harbor Asset Management’s Iovance Biotherapeutics IOVA Stock Holding History

Clear Harbor Asset Management’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-35,250
Closed -$117K – 423
2025
Q1 		$117K Buy
35,250
+11,700
+50% +$60.3K 0.01% 386
2024
Q4 		$174K Buy
23,550
+6,000
+34% +$55.6K 0.01% 353
2024
Q3 		$165K Sell
17,550
-13,250
-43% -$126K 0.01% 343
2024
Q2 		$247K Buy
+30,800
New +$330K 0.02% 315
2024
Q1 		– Sell
-11,000
Closed -$89.4K – 387
2023
Q4 		$89.4K Buy
+11,000
New +$57.6K 0.01% 353
2022
Q3 		– Sell
-6,625
Closed -$73K – 376
2022
Q2 		$73K Buy
+6,625
New +$86.8K 0.01% 374

Other funds holding IOVA

MFM
MHR Fund Management New York $1.37B AUM 68.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $2.28B AUM 7.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.17B AUM 0.03% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return